SITE THERAPEUTICS Trademark

Trademark Overview


On Tuesday, April 2, 2024, a trademark application was filed for SITE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SITE THERAPEUTICS trademark a serial number of 98480810. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 28, 2025. This trademark is owned by Site TX, Inc.. The SITE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; research and development in the field of genome engineering; research and development in functional genomics for use in the fields of immunology and inflammation; medical research for use in conducting in-cell, endogenously contextualized deep mutational scanning in the field of genomics; medical and scientific research; medical and scientific research, namely, screening cell phenotypes; pharmaceutical research for small molecule drug discovery and development; pharmaceutical research, namely, research relating to genomics for improving pharmacological properties; pharmaceutical research, namely, research relating to genomics for use in connection with a wide variety of therapeutic agents; medical and scientific research for use in the fields of immunology and inflammation; pharmaceutical research for small molecule drug discovery and development for use in the fields of immunology and inflammation
site therapeutics

General Information


Serial Number98480810
Word MarkSITE THERAPEUTICS
Filing DateTuesday, April 2, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 28, 2025

Trademark Statements


NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development; research and development in the field of genome engineering; research and development in functional genomics for use in the fields of immunology and inflammation; medical research for use in conducting in-cell, endogenously contextualized deep mutational scanning in the field of genomics; medical and scientific research; medical and scientific research, namely, screening cell phenotypes; pharmaceutical research for small molecule drug discovery and development; pharmaceutical research, namely, research relating to genomics for improving pharmacological properties; pharmaceutical research, namely, research relating to genomics for use in connection with a wide variety of therapeutic agents; medical and scientific research for use in the fields of immunology and inflammation; pharmaceutical research for small molecule drug discovery and development for use in the fields of immunology and inflammation

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 2, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSite TX, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDover, DE 19904

Party NameSite TX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDover, DE 19904

Trademark Events


Event DateEvent Description
Tuesday, April 2, 2024NEW APPLICATION ENTERED
Sunday, September 8, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 16, 2024ASSIGNED TO EXAMINER
Tuesday, October 22, 2024NON-FINAL ACTION WRITTEN
Tuesday, October 22, 2024NON-FINAL ACTION E-MAILED
Tuesday, October 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 10, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 10, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 2, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 28, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED